Medi-Caps Ltd
MEDICAPQMedi-Caps Ltd
MEDICAPQ
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -38.56 | 0.54 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Medi-Caps is a pharmaceutical company manufacturing allopathic pharmaceutical preparations
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 43.65 | 46.07 | 54.77 | 54.52 | 45.92 | 59.30 | 71.82 | 50.97 | 27.83 | 27.71 | ||||||||||
Raw Materials | 23.09 | 20.25 | 22.77 | 24.55 | 21.92 | 27.78 | 27.56 | 20.35 | 7.67 | 26.74 | ||||||||||
| Power & Fuel Cost | 5.02 | 4.74 | 5.29 | 5.14 | 3.86 | 2.64 | 3.35 | 2.25 | 1.55 | |||||||||||
| Employee Cost | 7.30 | 8.11 | 8.27 | 8.96 | 10.70 | 4.95 | 5.62 | 5.65 | 5.21 | |||||||||||
| Selling & Administrative Expenses | 5.05 | 6.02 | 10.01 | 5.17 | 5.06 | 6.77 | 18.13 | 11.63 | 9.19 | |||||||||||
| Operating & Other expenses | -0.10 | 3.32 | 5.19 | 3.25 | 8.29 | 4.42 | 5.14 | 4.41 | 3.72 | |||||||||||
EBITDA | 3.29 | 3.63 | 3.24 | 7.45 | -3.91 | 12.74 | 12.02 | 6.68 | 0.49 | 0.97 | ||||||||||
| Depreciation/Amortization | 1.80 | 1.81 | 1.79 | 1.82 | 1.83 | 1.52 | 1.81 | 1.74 | 1.69 | 1.65 | ||||||||||
| PBIT | 1.49 | 1.82 | 1.45 | 5.63 | -5.74 | 11.22 | 10.21 | 4.94 | -1.20 | -0.68 | ||||||||||
| Interest & Other Items | 0.06 | 0.10 | 0.10 | 0.13 | 0.12 | 0.10 | 0.11 | 0.13 | 0.04 | — | ||||||||||
| PBT | 1.43 | 1.72 | 1.35 | 5.50 | -5.86 | 11.12 | 10.10 | 4.81 | -1.24 | -0.68 | ||||||||||
| Taxes & Other Items | 0.56 | 0.35 | 0.20 | 0.12 | 0.01 | -0.01 | 0.01 | 3.06 | 1.00 | 1.00 | ||||||||||
| Net Income | 0.87 | 1.37 | 1.15 | 5.38 | -5.87 | 11.13 | 10.09 | 1.75 | -2.24 | -1.68 | ||||||||||
| EPS | 0.70 | 1.10 | 0.92 | 4.31 | -4.71 | 8.93 | 8.09 | 1.40 | -1.80 | -1.35 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Medi-Caps Ltd | -28.92 | 0.54 | — |
| Sun Pharmaceutical Industries Ltd | 45.34 | 6.47 | 0.75% |
| Cipla Ltd | 31.21 | 4.80 | 0.82% |
| Torrent Pharmaceuticals Ltd | 65.38 | 15.80 | 0.88% |
Price Comparison
Compare MEDICAPQ with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
MEDICAPQ has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2012
Dividend/Share
₹1.50
Ex DateEx Date
Sep 20, 2012
Cash Dividend
Ex DateEx DateSep 22, 2011
Dividend/Share
₹1.50
Ex DateEx Date
Sep 22, 2011
Medi Caps will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Medi Caps announced that the 41th Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live
Net Loss of Medi Caps reported to Rs 0.56 crore in the quarter ended June 2024 as against net loss of Rs 1.11 crore during the previous quarter ended June 2023. Sales declined 1.44% to Rs 6.15 crore in the quarter ended June 2024 as against Rs 6.24 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales6.156.24 -1 OPM %-4.55-11.70 - PBDT-0.13-0.66 80 PBT-0.56-1.11 50 NP-0.56-1.11 50 Powered by Capital Market - Live
Medi Caps will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live
Medi-Caps Standalone December 2023 Net Sales at Rs 3.05 crore, up 23895.28% Y-o-Y
Medi Caps reports standalone net loss of Rs 0.14 crore in the December 2022 quarter
Medi-Caps secures RERA nod on Medicaps Business Park project
Medi Caps gets approval under RERA for Real Estate Project ‘Medicaps Business Park’
Medi Caps consolidated net profit rises 3.91% in the September 2021 quarter
Medi Caps consolidated net profit rises 58.77% in the June 2021 quarter
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -12.58%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.02% to 0.01%